{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gui : Questions médicales les plus fréquentes",
"headline": "Gui : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gui : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gui"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Magnoliopsida",
"url": "https://questionsmedicales.fr/mesh/D019684",
"about": {
"@type": "MedicalCondition",
"name": "Magnoliopsida",
"code": {
"@type": "MedicalCode",
"code": "D019684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Loranthaceae",
"alternateName": "Loranthaceae",
"url": "https://questionsmedicales.fr/mesh/D028183",
"about": {
"@type": "MedicalCondition",
"name": "Loranthaceae",
"code": {
"@type": "MedicalCode",
"code": "D028183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.735.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Viscaceae",
"alternateName": "Viscaceae",
"url": "https://questionsmedicales.fr/mesh/D028163",
"about": {
"@type": "MedicalCondition",
"name": "Viscaceae",
"code": {
"@type": "MedicalCode",
"code": "D028163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.735.888"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Gui",
"alternateName": "Mistletoe",
"code": {
"@type": "MedicalCode",
"code": "D014784",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jutta Huebner",
"url": "https://questionsmedicales.fr/author/Jutta%20Huebner",
"affiliation": {
"@type": "Organization",
"name": "Klinik Für Innere Medizin II, Hämatologie Und Onkologie, Universitätsklinikum Jena, Jena, Germany."
}
},
{
"@type": "Person",
"name": "Jin Chen",
"url": "https://questionsmedicales.fr/author/Jin%20Chen",
"affiliation": {
"@type": "Organization",
"name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China."
}
},
{
"@type": "Person",
"name": "Ling Zhang",
"url": "https://questionsmedicales.fr/author/Ling%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China. zhangl@xtbg.org.cn."
}
},
{
"@type": "Person",
"name": "David M Watson",
"url": "https://questionsmedicales.fr/author/David%20M%20Watson",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Peiying Yang",
"url": "https://questionsmedicales.fr/author/Peiying%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Departments of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Texas, Houston, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.",
"datePublished": "2024-10-31",
"url": "https://questionsmedicales.fr/article/39482761",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-024-03418-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37098795",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/art.42510"
}
},
{
"@type": "ScholarlyArticle",
"name": "A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/36787101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/art.42477"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced by Toll-like Receptor CD180 Ligation in Diffuse Cutaneous Systemic Sclerosis.",
"datePublished": "2024-08-26",
"url": "https://questionsmedicales.fr/article/39273179",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179230"
}
},
{
"@type": "ScholarlyArticle",
"name": "Purtscher-Like Retinopathy Induced by Diffuse Cutaneous Systemic Scleroderma.",
"datePublished": "2023-11-09",
"url": "https://questionsmedicales.fr/article/37950491",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/qjmed/hcad255"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Viridiplantae",
"item": "https://questionsmedicales.fr/mesh/D057948"
},
{
"@type": "ListItem",
"position": 4,
"name": "Streptophyta",
"item": "https://questionsmedicales.fr/mesh/D057949"
},
{
"@type": "ListItem",
"position": 5,
"name": "Embryophyta",
"item": "https://questionsmedicales.fr/mesh/D019669"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tracheobionta",
"item": "https://questionsmedicales.fr/mesh/D064028"
},
{
"@type": "ListItem",
"position": 7,
"name": "Magnoliopsida",
"item": "https://questionsmedicales.fr/mesh/D019684"
},
{
"@type": "ListItem",
"position": 8,
"name": "Gui",
"item": "https://questionsmedicales.fr/mesh/D014784"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gui - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gui",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gui",
"description": "Comment diagnostiquer une intoxication au gui ?\nQuels tests sont utilisés pour le gui en médecine ?\nQuels signes cliniques indiquent une réaction au gui ?\nLe gui peut-il être détecté par imagerie ?\nComment différencier le gui des autres plantes ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gui",
"description": "Quels sont les symptômes d'une intoxication au gui ?\nLe gui provoque-t-il des allergies ?\nQuels effets secondaires sont associés au gui ?\nLe gui peut-il causer des troubles respiratoires ?\nQuels symptômes sont liés à l'utilisation thérapeutique du gui ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gui",
"description": "Comment prévenir l'intoxication au gui ?\nLe gui est-il dangereux pour les animaux ?\nComment identifier le gui dans la nature ?\nQuelles précautions prendre lors de la récolte du gui ?\nLe gui peut-il être cultivé en toute sécurité ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gui",
"description": "Comment traiter une intoxication au gui ?\nLe gui est-il utilisé en oncologie ?\nQuels médicaments interagissent avec le gui ?\nLe gui peut-il être utilisé en phytothérapie ?\nQuels sont les traitements alternatifs au gui ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gui",
"description": "Quelles complications peuvent survenir avec le gui ?\nLe gui peut-il causer des problèmes cardiaques ?\nQuels sont les risques d'une surconsommation de gui ?\nLe gui peut-il affecter la grossesse ?\nQuelles sont les conséquences d'une réaction allergique au gui ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gui",
"description": "Qui est à risque d'intoxication au gui ?\nLes personnes allergiques au gui sont-elles plus à risque ?\nLe risque d'intoxication varie-t-il selon la région ?\nLes personnes âgées sont-elles plus vulnérables au gui ?\nLes utilisateurs de médecines alternatives sont-ils à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Scleroderma,+Diffuse&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication au gui ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'intoxication se diagnostique par l'examen des symptômes cliniques et l'historique d'exposition."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le gui en médecine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent être effectués pour évaluer les niveaux de toxines en cas d'intoxication."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une réaction au gui ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des nausées, des vomissements, des troubles respiratoires et des convulsions."
}
},
{
"@type": "Question",
"name": "Le gui peut-il être détecté par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le gui ne peut pas être détecté par imagerie, mais ses effets peuvent l'être indirectement."
}
},
{
"@type": "Question",
"name": "Comment différencier le gui des autres plantes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le gui se distingue par ses baies blanches et sa croissance sur d'autres arbres, souvent en hiver."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication au gui ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Le gui provoque-t-il des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques au gui, comme des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont associés au gui ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des effets neurologiques."
}
},
{
"@type": "Question",
"name": "Le gui peut-il causer des troubles respiratoires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'ingestion de gui peut entraîner des difficultés respiratoires dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'utilisation thérapeutique du gui ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme la fatigue, des maux de tête et des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'intoxication au gui ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de consommer des baies de gui et éduquez-vous sur les plantes toxiques."
}
},
{
"@type": "Question",
"name": "Le gui est-il dangereux pour les animaux ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le gui est toxique pour de nombreux animaux, notamment les chiens et les chats."
}
},
{
"@type": "Question",
"name": "Comment identifier le gui dans la nature ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le gui se reconnaît par ses feuilles ovales et ses baies blanches, souvent sur des arbres."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de la récolte du gui ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Portez des gants et évitez le contact direct avec la sève pour prévenir les irritations."
}
},
{
"@type": "Question",
"name": "Le gui peut-il être cultivé en toute sécurité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il faut suivre des pratiques de culture appropriées pour éviter les risques d'intoxication."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication au gui ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'évacuation du contenu gastrique et des soins symptomatiques en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Le gui est-il utilisé en oncologie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le gui est parfois utilisé comme traitement complémentaire en oncologie, bien que son efficacité soit débattue."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec le gui ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le gui peut interagir avec des anticoagulants et d'autres médicaments, nécessitant une prudence."
}
},
{
"@type": "Question",
"name": "Le gui peut-il être utilisé en phytothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le gui est utilisé en phytothérapie pour ses propriétés supposées, mais avec précaution."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs au gui ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs incluent des remèdes à base de plantes, mais leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le gui ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles gastro-intestinaux graves et des réactions allergiques sévères."
}
},
{
"@type": "Question",
"name": "Le gui peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intoxication sévère au gui peut entraîner des arythmies cardiaques et d'autres problèmes."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surconsommation de gui ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des symptômes graves, y compris des convulsions et un coma."
}
},
{
"@type": "Question",
"name": "Le gui peut-il affecter la grossesse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le gui peut être dangereux pendant la grossesse et doit être évité par précaution."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une réaction allergique au gui ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure un choc anaphylactique, nécessitant une intervention médicale urgente."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication au gui ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants et les animaux domestiques sont particulièrement à risque d'intoxication au gui."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques au gui sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies aux plantes sont plus à risque."
}
},
{
"@type": "Question",
"name": "Le risque d'intoxication varie-t-il selon la région ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines régions ont une plus grande prévalence de gui, augmentant le risque d'intoxication."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables au gui ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets toxiques du gui."
}
},
{
"@type": "Question",
"name": "Les utilisateurs de médecines alternatives sont-ils à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ceux qui utilisent le gui sans supervision médicale peuvent être à risque d'intoxication."
}
}
]
}
]
}
Patients with diffuse cutaneous systemic sclerosis (dcSSc) frequently show spontaneous improvement of skin fibrosis. Our aim was to examine whether an improvement in skin fibrosis predicts lower likel...
Patients from the European Scleroderma Trials and Research (EUSTAR) cohort with dcSSc, baseline modified Rodnan skin score (mRSS) ≥7, and valid mRSS at 12±3 months follow up were included. Regression/...
Of 1257 included patients, 883 (70.2%) were stable, 282 (22.4%) regressive, and 92 (7.3%) progressive. Regressive patients, adjusted for baseline mRSS, baseline immunosuppression, baseline FVC, and di...
We found that regression of skin fibrosis is associated with a lower probability of lung progression and better survival at follow up. The link between the disease course of skin and lung fibrosis in ...
This phase 3 study was undertaken to investigate the efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in patients with diffuse cutaneous systemic sclerosis (dcSSc)....
A multinational double-blind study was conducted in 365 dcSSc patients who were randomized and dosed 1:1:1 with lenabasum 20 mg, lenabasum 5 mg, or placebo, each twice daily and added to background tr...
The primary end point, the American College of Rheumatology combined response index in dcSSc (CRISS) at week 52 for lenabasum 20 mg twice a day versus placebo, was not met, with CRISS score of 0.888 v...
A benefit of lenabasum in dcSSc was not demonstrated. Most patients were treated with background IST, and treatment with mycophenolate mofetil in particular was associated with better outcomes. These ...
We undertook this study to explore the efficacy, safety, and tolerability of ziritaxestat, a selective autotaxin inhibitor, in patients with early diffuse cutaneous systemic sclerosis (dcSSc)....
NOVESA was a 24-week, multicenter, phase IIa, double-blind, placebo-controlled study. Adults with dcSSc were randomized to oral ziritaxestat 600 mg once daily or matching placebo. The primary efficacy...
Patients were randomized to ziritaxestat (n = 21) or placebo (n = 12). Reduction in MRSS was significantly greater in the ziritaxestat group versus the placebo group (-8.9 versus -6.0 units, respectiv...
Ziritaxestat resulted in significantly greater reduction in MRSS at week 24 than placebo; no new safety signals emerged. Biomarker analysis suggests ziritaxestat may reduce fibrosis. Modulation of the...
Autoantibody production is a hallmark of systemic sclerosis (SSc) and the most extensively studied role of B cells in the pathogenesis of the disease. However, the potential involvement of innate immu...
We report a rare case of Purtscher-like retinopathy related to systemic sclerosis, presented unprecedently an ultra-widefield optical coherence tomography angiography image for this combination, and s...
Keloidal scleroderma is a variant of scleroderma that presents as firm keloidal nodules or plaques. Due to the similarity in morphology and pathology, it is often distinguished from a hypertrophic sca...
Scleroderma is a systemic inflammatory disorder that can compromise the gastrointestinal tract in up to 90% of patients....
The purpose of this work is to characterize esophageal, gastric, and intestinal compromise in patients with scleroderma by means of minimally invasive methods and its association with symptoms and sev...
Patients with systemic sclerosis were recruited according to the criteria of the American College of Rheumatology. The study of digestive involvement was carried out on four consecutive days: esophage...
A total of 30 patients were included, with an average age of 52.7 years and 93% women. Average disease evolution duration was 6.5 years, 70% with limited variety. Rodnan averaged 12 points, being high...
Gastrointestinal involvement in patients with scleroderma is frequent and is observed regardless of the symptoms and clinical characteristics of the latter, except for skin involvement....
Systemic sclerosis is a systemic connective tissue disease whose main pathophysiological mechanism is a progressive fibrosis of internal organs and skin leading to thickening and induration. Blood ves...
Immune checkpoint inhibitors (ICI) are the standard of care for various malignancies and have been associated with a wide spectrum of complications that are phenotypically akin to primary autoimmune d...